Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Environ Toxicol ; 35(7): 783-793, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32096903

RESUMEN

The primary metabolize of chlorpyrifos (CPF) is in the liver tissue, which it can cause oxidative damage and apoptosis in liver cells. The use of exercise with antioxidant supplements could have a protective effects in the liver tissue especially by improve mitochondria function. The aim of the present study was to investigate the protective effect of aerobic exercise and eugenol (Eu) supplementation on destructive effects of CPF in liver tissue. Sixty-four adult male albino rats were randomly divided into eight groups (eight rats in each group). Four experimental groups received intraperitoneal injection of either 3.0 mg/kg body weight CPF in dimethyl sulfoxide for six consecutive weeks. Aerobic exercise was performed 5 days per week over 4 weeks for exercise groups. Finally, the animals were sacrificed for the histomorphometric analysis and biochemical measurement in the liver tissue. The result of this study show that consumption of CPF alone, caused collagen deposition, increased apoptosis, tumor necrosis factor α, malondialdehyde, and decreased catalase, superoxide dismutase, acetylcholinesterase (AChE) compared to control and exercise groups (healthy groups) in liver tissue (P ˂ .05). Prescription of exercises and Eu supplements in CPF consumer groups, neutralized this destructive effects of CPF. However, concomitant administration of Eu with exercise had better effects on liver tissue (P ˂ .05). It seems that consumption of Eu with aerobic exercise have a protective role in tissue destruction, inflammatory damage by improving antioxidant defense and modulating AChE activity in hepatocytes.


Asunto(s)
Acetilcolinesterasa/metabolismo , Antioxidantes/metabolismo , Cloropirifos/toxicidad , Eugenol/farmacología , Hígado/efectos de los fármacos , Condicionamiento Físico Animal , Animales , Catalasa/metabolismo , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Enfermedad Hepática Inducida por Sustancias y Drogas/prevención & control , Suplementos Dietéticos , Hígado/enzimología , Masculino , Malondialdehído/metabolismo , Estrés Oxidativo/efectos de los fármacos , Distribución Aleatoria , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo
2.
J Strength Cond Res ; 28(9): 2560-8, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24662224

RESUMEN

Regular exercise training has been shown to reduce systemic inflammation, but there is limited research directly comparing different types of training. The purpose of this study was to compare the effects of nonlinear resistance training (NRT) and aerobic interval training (AIT) on serum interleukin-10 (IL-10), IL-20, and tumor necrosis factor-α (TNF-α) levels, insulin resistance index (homeostasis model assessment of insulin resistance), and aerobic capacity in middle-aged men who are obese. Sedentary volunteers were assigned to NRT (n = 12), AIT (n = 12), and (CON, n = 10) control groups. The experimental groups performed 3 weekly sessions for 12 weeks, whereas the CON grouped maintained a sedentary lifestyle. Nonlinear resistance training consisted of 40-65 minutes of weight training at different intensities with flexible periodization. Aerobic interval training consisted of running on a treadmill (4 sets of 4 minutes at 80-90% of maximal heart rate, with 3-minute recovery intervals). Serum IL-10, IL-20, and TNF-α levels did not change significantly in response to training (all p > 0.05), but IL-10:TNF-α ratio increased significantly with AIT compared with CON (2.95 ± 0.84 vs. 2.52 ± 0.65; p = 0.02). After the training period, maximal oxygen uptake increased significantly in AIT and NRT compared with CON (both p < 0.001; 46.7 ± 5.9, 45.1 ± 3.2, and 41.1 ± 4.7 ml·kg·min, respectively) and in AIT than in NRT (p = 0.001). The 2 exercise programs were equally effective at reducing insulin resistance (homeostasis model assessment for insulin resistance) (both p ≤ 0.05; AIT: 0.84 ± 0.34, NRT: 0.84 ± 0.27, and CON: 1.62 ± 0.56) and fasting insulin levels (both p ≤ 0.05; AIT: 3.61 ± 1.48, NRT: 3.66 ± 0.92, and CON: 6.20 ± 2.64 µU·ml), but the AIT seems to have better anti-inflammatory effects (as indicated by the IL-10:TNF-α ratio) compared with NRT.


Asunto(s)
Citocinas/sangre , Inflamación/sangre , Resistencia a la Insulina , Obesidad/fisiopatología , Carrera/fisiología , Levantamiento de Peso/fisiología , Adulto , Ayuno/sangre , Humanos , Inflamación/etiología , Inflamación/terapia , Insulina/sangre , Interleucina-10/sangre , Interleucinas/sangre , Masculino , Persona de Mediana Edad , Obesidad/complicaciones , Obesidad/terapia , Consumo de Oxígeno , Entrenamiento de Fuerza , Conducta Sedentaria , Factor de Necrosis Tumoral alfa/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA